Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Drug Companies Hide Data From Docs

Edited info could mislead those prescribing meds

By Katherine Thompson, Newser Staff

Posted Nov 26, 2008 10:22 AM CST

(Newser) – Pharmaceutical companies aren't as upfront with doctors as they are with the government about their new products, a study finds. Though drug companies must provide the FDA with all of the data from clinical trials, related papers published in medical journals were found to omit... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

There are no comments

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

What's Popular Now on Facebook

Cops Shoot Naked Guy Eating Man's Face on Highway

Japanese Artist Serves Up Own Cooked Genitals

Wired (Source Grid »)

The study
PLoS Journal of Medicine

Additional commentary on the FDA
PLoS Journal of Medicine

FDA moral and credibility are low
Washington Post

Health

FDA • Merck • pharmaceutical companies • Avandia • Vioxx • prescription drugs • prescription • side effects • Vytorin • doctors

More Newser Stories

Drug Company Nemesis Strikes Again

Crusading cardiologist took on Vioxx, now Avandia, for heart risks

(NEWSER) - The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug risks. More»

Drug Labels List an Average 70 Side Effects

Pharmaceutical companies trying to protect themselves from litigation

(NEWSER) - Take a gander at your typical prescription drug label, and you’ll see a lot more side effects than even the fastest talker could rattle off at the end of a commercial. The average label warns of a staggering 70 side effects, according to a new study that reviewed 5,600 such labels. But that’s mostly because drug makers want to protect themselves from every possible lawsuit, rather than because of real dangers, researchers tell Live Science . More»

US Prescription Drugs Tested on World's Poor

Drugs declared 'safe' on basis of unregulated trials abroad

(NEWSER) - Prescription drugs that are considered safe kill an estimated 200,000 Americans a year, and investigative reporters Donald L. Barlett and James B. Steele have exposed a massive loophole that could help explain why. Some 6,485 clinical trials were conducted abroad in 2008—more than 20 times as many as in 1990—and the FDA has been declaring drugs safe based on foreign trials that are almost completely free from regulation or oversight, a detailed investigation published in Vanity Fair finds. More»

FDA Restricts Diabetes Drug Over Heart Risk

But regulators stop short of an outright ban on Avandia

(NEWSER) - The FDA today put severe restrictions on Avandia, GlaxoSmithKline’s embattled diabetes drug, but stopped short of banning it outright. The once-popular drug will now only be available only as a last resort to type 2 diabetes patients who can’t control their glucose levels with any other medication, the AFP reports. Avandia has come under fire because data suggests it carries, in the FDA’s words, “an elevated risk of cardiovascular events” like heart attacks and strokes. More»

Avandia Woes Mount Ahead of FDA Hearing

Agency flags flawed study, may ban diabetes drug

(NEWSER) - As the FDA prepares to consider whether to ban Avandia, agency scientists have discovered another problem with the diabetes drug: flaws that disqualify a clinical study sponsored by its maker. The trial, organized by GlaxoSmithKline, sought to evaluate the relative heart risks of Avandia and two other diabetes drugs, but was an "open label" trial, meaning the researchers and patients knew which drugs they were getting, USA Today reports. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

Drug Companies Hide Data From Docs

Edited info could mislead those prescribing meds

FDA • Merck • pharmaceutical companies • Avandia • Vioxx • prescription drugs • prescription • side effects • Vytorin • doctors

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

Drug Company Nemesis Strikes Again

Crusading cardiologist took on Vioxx, now Avandia, for heart risks

Drug Labels List an Average 70 Side Effects

Pharmaceutical companies trying to protect themselves from litigation

US Prescription Drugs Tested on World's Poor

Drugs declared 'safe' on basis of unregulated trials abroad

FDA Restricts Diabetes Drug Over Heart Risk

But regulators stop short of an outright ban on Avandia

Avandia Woes Mount Ahead of FDA Hearing

Agency flags flawed study, may ban diabetes drug

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?